Full Year 2019 BioNTech SE Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the BioNTech fourth quarter and full year operational progress and financial results call. (Operator Instructions) I must advise you this call is being recorded today, Tuesday, the 31st of March, 2020.
And I would now like to hand the call over to the Vice President, Investor Relations and Business Strategy, Sylke Maas. Please go ahead.
Thank you for joining us today for BioNTech's Fourth Quarter and Full Year 2019 Update Call. Before we start, we encourage you to view the slides for this webcast as well as the financial results press release issued this morning, both of which are accessible on our website in the Investors section. Slides 2 and 3 provides legal disclosures related to the pending acquisition of Neon Therapeutics.
As shown on Slide 4, during today's presentation, we will be making several forward-looking statements. These forward-looking statements include, but are not limited to, the timing for enrollment
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |